Current role of PET/CT in evaluation of lung cancer

By Partha Ghosh, MD, Siemens Healthineers; and Dimitre Hristov, PhD, Department of Radiation Oncology, Stanford University


Lung cancer is the second most common cancer in both men and women and the leading cause of death in the USA.1 Detection and assessment of primary tumor and of mediastinal nodal and distant metastases through a combination of imaging modalities is key to proper staging. Learn how FDG PET/CT plays an important role in all aspects of management of lung cancer by downloading the following white paper.